Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Rudwaleit

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2006
Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenonCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
RMD Open|May 9, 2024
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP statusMartin Rudwaleit, Atul Deodhar, Lars Bauer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
Annals of the Rheumatic Diseases|May 5, 2011
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritisDésirée van der Heijde, Joachim Sieper, Walter P Maksymowych, et al.
Annals of the Rheumatic Diseases|August 6, 2015
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)Joachim Sieper, Joachim Listing, Denis Poddubnyy, et al.
Rheumatology (Oxford, England)|March 5, 2019
Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritisJudith Rademacher, Lorraine Madeline Tietz, Lien Le, et al.
Clinical and Experimental Rheumatology|April 4, 2020
IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritisTorsten Witte, Maria Köhler, Joachim Georgi, et al.
Arthritis Research & Therapy|August 24, 2006
Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitisHeiner Appel, Christoph Loddenkemper, Zarko Grozdanovic, et al.
The Journal of Rheumatology|October 9, 2007
In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitisHeiner Appel, Rebecca Scheer, Hildrun Haibel, et al.
The Journal of Rheumatology|March 11, 2009
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitisMartin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 3, 2006
Coronary vasospasm-induced acute diastolic dysfunction in a patient with Raynaud's phenomenonCarsten Tschöpe, Dirk Westermann, Paul Steendijk, et al.
RMD Open|May 9, 2024
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP statusMartin Rudwaleit, Atul Deodhar, Lars Bauer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.
Annals of the Rheumatic Diseases|May 5, 2011
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritisDésirée van der Heijde, Joachim Sieper, Walter P Maksymowych, et al.
Annals of the Rheumatic Diseases|August 6, 2015
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)Joachim Sieper, Joachim Listing, Denis Poddubnyy, et al.
Rheumatology (Oxford, England)|March 5, 2019
Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritisJudith Rademacher, Lorraine Madeline Tietz, Lien Le, et al.
Clinical and Experimental Rheumatology|April 4, 2020
IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritisTorsten Witte, Maria Köhler, Joachim Georgi, et al.
Arthritis Research & Therapy|August 24, 2006
Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitisHeiner Appel, Christoph Loddenkemper, Zarko Grozdanovic, et al.
The Journal of Rheumatology|October 9, 2007
In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitisHeiner Appel, Rebecca Scheer, Hildrun Haibel, et al.
The Journal of Rheumatology|March 11, 2009
Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitisMartin Rudwaleit, Pascal Claudepierre, Paul Wordsworth, et al.
Pageof 15